Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders
– Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI – – Sunbird will use additional funds to further clinical development of validated diagnostic technology across key protein biomarkers in…